Lbj Family Wealth Advisors, Ltd. Reata Pharmaceuticals Inc Transaction History

Lbj Family Wealth Advisors, Ltd.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 03, 2023	SELL	$79.22 - $105.37 $340,883 - $453,407	-4,303 Reduced 14.39%	25,604 $2.61 Million
Q1 2023 Apr 11, 2023	SELL	$30.85 - $93.17 $13,944 - $42,112	-452 Reduced 1.49%	29,907 $2.72 Million
Q2 2021 Jul 02, 2021	SELL	$78.27 - $151.29 $704 - $1,361	-9 Reduced 0.03%	30,359 $4.3 Million
Q1 2020 Apr 02, 2020	SELL	$124.16 - $247.74 $1.7 Million - $3.4 Million	-13,728 Reduced 31.13%	30,368 $4.38 Million
Q2 2019 Jul 18, 2019	SELL	$77.72 - $94.35 $723,417 - $878,209	-9,308 Reduced 17.43%	44,096 $3.71 Million
Q4 2018 Jan 11, 2019	SELL	$48.76 - $76.44 $359,409 - $563,439	-7,371 Reduced 12.13%	53,404 $3 Million
Q3 2018 Oct 01, 2018	SELL	$35.64 - $92.06 $1.05 Million - $2.71 Million	-29,425 Reduced 32.62%	60,775 $4.97 Million
Q3 2017 Oct 03, 2017	BUY	$26.29 - $31.88 $2.37 Million - $2.88 Million	90,200	90,200 $2.81 Million

62.7K

Ticker RETA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,583,200
Description
Reata Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, identifies, develops, and commercializes novel therapeutics for patients with serious or life-threatening diseases. The company is developing Phase 3 clinical trial programs, including bardoxolone methyl (bardoxolone) for the treatment of patients with chronic kidney diseas...

Get notified when there are updates to the investment portfolio of Lbj Family Wealth Advisors, Ltd., based on Form 13F filings with the SEC.

Stay updated on Lbj Family Wealth Advisors, Ltd. with notifications on news.